WuXi Biologics (Cayman) Balance Sheet Health
Financial Health criteria checks 5/6
WuXi Biologics (Cayman) has a total shareholder equity of CN¥44.0B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 4.9%. Its total assets and total liabilities are CN¥56.6B and CN¥12.6B respectively. WuXi Biologics (Cayman)'s EBIT is CN¥3.9B making its interest coverage ratio -64.8. It has cash and short-term investments of CN¥11.2B.
Key information
4.9%
Debt to equity ratio
CN¥2.15b
Debt
Interest coverage ratio | -64.8x |
Cash | CN¥11.24b |
Equity | CN¥44.02b |
Total liabilities | CN¥12.56b |
Total assets | CN¥56.58b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: WXIB.F's short term assets (CN¥21.2B) exceed its short term liabilities (CN¥7.6B).
Long Term Liabilities: WXIB.F's short term assets (CN¥21.2B) exceed its long term liabilities (CN¥4.9B).
Debt to Equity History and Analysis
Debt Level: WXIB.F has more cash than its total debt.
Reducing Debt: WXIB.F's debt to equity ratio has increased from 0% to 4.9% over the past 5 years.
Debt Coverage: WXIB.F's debt is well covered by operating cash flow (258.1%).
Interest Coverage: WXIB.F earns more interest than it pays, so coverage of interest payments is not a concern.